AKG-210

N/A

Report date: 2026/05/12 09:17:25

Base Information

Drug NameAKG-210
Drug Alias NameAKG-210
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkagera Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkagera Medicines Inc
Inactive CompaniesTScan Therapeutics Inc
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A